{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:45Z","timestamp":1793701365730,"version":"4.5.1"},"reference-count":195,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jhep.2023.04.021","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T13:11:03Z","timestamp":1687612263000},"page":"461-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":393,"title":["EASL Clinical Practice Guidelines on acute-on-chronic liver failure"],"prefix":"10.1016","volume":"79","author":[{"given":"Richard","family":"Moreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Gustot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2021.06.018","article-title":"Towards a new definition of decompensated cirrhosis","volume":"76","author":"D\u2019Amico","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-Chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","article-title":"PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis","volume":"74","author":"Trebicka","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"22","key":"10.1016\/j.jhep.2023.04.021_bib4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-Chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2023.04.021_bib5","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jhep.2020.11.047","article-title":"Acute-on-chronic liver failure: a distinct clinical syndrome","volume":"75","author":"Moreau","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"issue":"S1","key":"10.1016\/j.jhep.2023.04.021_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/liv.14855","article-title":"Acute-on-chronic liver failure: where do we stand?","volume":"41","author":"Durand","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib9","article-title":"Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment","volume":"3","author":"Zaccherini","year":"2021","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"European Association for the Study of the Liver M. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jhep.2018.10.011","article-title":"European association for the study of the liver. Clinical practice guidelines of the European association for the study of the liver - advancing methodology but preserving practicability","volume":"70","author":"Cornberg","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.04.021_bib12","unstructured":"OCEBM Levels of Evidence Working Group\u2217. \u201cThe Oxford Levels of Evidence 2\u201d. Oxford Centre for Evidence-Based Medicine. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib14","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure","volume":"67","author":"Wu","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib16","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/hep.29773","article-title":"NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis","volume":"67","author":"O\u2019leary","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jhep.2020.06.005","article-title":"Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure","volume":"73","author":"Hernaez","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2021.05.033","article-title":"EASL-CLIF criteria outperform NACSELD criteria for diagnosis and prognostication in ACLF","volume":"75","author":"Li","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib19","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.14309\/ajg.0000000000000771","article-title":"The use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis","volume":"115","author":"Cao","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib20","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and mortality\u00a0of acute-on-chronic liver failure using two definitions in patients\u00a0with compensated cirrhosis","volume":"69","author":"Mahmud","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146745","article-title":"Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00134-019-05907-4","article-title":"Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies","volume":"46","author":"Slooter","year":"2020","journal-title":"Intensive Care Med"},{"issue":"21","key":"10.1016\/j.jhep.2023.04.021_bib23","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3748\/wjg.v25.i21.2675","article-title":"Proton pump inhibitor use increases hepatic encephalopathy risk: a systematic review and meta-analysis","volume":"25","author":"Ma","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.021_bib24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/00365521.2017.1369560","article-title":"Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure","volume":"52","author":"Alexopoulou","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"28","key":"10.1016\/j.jhep.2023.04.021_bib28","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.3748\/wjg.v23.i28.5237","article-title":"Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores preDict mortality in Brazilian cirrhotic patients","volume":"23","author":"Picon","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/hepr.12751","article-title":"Risk stratification of decompensated cirrhosis patients by Chronic Liver Failure Consortium scores: classification and regression tree analysis","volume":"47","author":"Shi","year":"2017","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12876-018-0911-y","article-title":"Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis","volume":"18","author":"Gao","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2023.04.021_bib31","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.922121","article-title":"Acute-on-chronic liver failure: the role of prognostic scores in a single-center experience","volume":"26","author":"Niewinski","year":"2020","journal-title":"Med Sci Monit"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib32","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1007\/s10620-020-06791-5","article-title":"CLIF-C AD score predicts development of acute decompensations and survival\u00a0in hospitalized cirrhotic patients","volume":"66","author":"Baldin","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2023.04.021_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9953106","article-title":"Comparison of general and liver-specific prognostic scores in their ability to predict mortality in cirrhotic patients admitted to the intensive care unit","volume":"2021","author":"Costa E Silva","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib34","article-title":"Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score","volume":"4","author":"Chang","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib35","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/hep4.1654","article-title":"Prognostic value of the CLIF-C AD score in patients with implantation of transjugular intrahepatic portosystemic shunt","volume":"5","author":"Sturm","year":"2021","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/hep4.1712","article-title":"Elective surgery but not transjugular intrahepatic portosystemic shunt precipitates acute-on-chronic liver failure","volume":"5","author":"Chang","year":"2021","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.021_bib37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.dld.2015.04.001","article-title":"Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit","volume":"47","author":"Dupont","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2023.04.021_bib38","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib39","first-page":"399","article-title":"CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with acute on chronic liver failure admitted to the ward","volume":"109","author":"Barosa","year":"2017","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"issue":"17","key":"10.1016\/j.jhep.2023.04.021_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006802","article-title":"Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: the CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.gastrohep.2017.01.001","article-title":"Comparaci\u00f3n del valor pron\u00f3stico de los modelos del Chronic Liver Failure\u00a0Consortium y modelos tradicionales para predecir la mortalidad en\u00a0pacientes con cirrosis","volume":"40","author":"Antunes","year":"2017","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib42","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jgh.13991","article-title":"Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure","volume":"33","author":"Song","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol (Australia)"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5604\/01.3001.0011.7384","article-title":"Comparison of dynamic changes among various prognostic scores in viral hepatitis-related acute liver failure","volume":"17","author":"Shalimar","year":"2018","journal-title":"Ann Hepatol"},{"issue":"278","key":"10.1016\/j.jhep.2023.04.021_bib44","first-page":"98","article-title":"Validation of CLIF-C-ACLF score for alcoholic liver cirrhosis","author":"Slyvka","year":"2018","journal-title":"Georgian Med News"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib45","doi-asserted-by":"crossref","first-page":"948","DOI":"10.5604\/01.3001.0012.7195","article-title":"Infection and predictors of outcome of cirrhotic patients after emergency care hospital admission","volume":"17","author":"Safi","year":"2018","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219516","article-title":"Validation of the prognostic models in acuteon-chronic liver failure precipitated by hepatic and extrahepatic insults","volume":"14","author":"Maipang","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jca.21762","article-title":"A\u00a0prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system","volume":"35","author":"Xie","year":"2020","journal-title":"J\u00a0Clin Apher"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib48","article-title":"Comparison of CLIF-C ACLF score and MELD score in predicting ICU mortality in patients with acute-on-chronic liver failure","volume":"12","author":"Ramzan","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib49","first-page":"1","article-title":"Comparing clif-c aclf, clif-c aclflactate, and clif-c aclf-d prognostic scores in acute-on-chronic liver failure patients by a single-center icu experience","volume":"11","author":"Kuo","year":"2021","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jhep.2023.04.021_bib50","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.926574","article-title":"Prognostic value of acute-on-chronic liver failure (ACLF) score in critically ill patients with cirrhosis and ACLF","volume":"26","author":"Lin","year":"2020","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib51","first-page":"3048","article-title":"The scoring systems in predicting short-term outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"9","author":"Li","year":"2020","journal-title":"Ann Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000522595","article-title":"Comparison of mortality prediction scores in intermediate-care patients with liver cirrhosis at a German university transplant center; a prospective study","volume":"41","author":"Jahn","year":"2023","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib53","first-page":"1540","article-title":"Comparing eight prognostic scores in predicting mortality of patients with acute-on-chronic liver failure who were admitted to an ICU: a single-center experience","volume":"9","author":"Chen","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13054-018-2156-0","article-title":"Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure","volume":"22","author":"Engelmann","year":"2018","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.21037\/atm-20-6180","article-title":"A\u00a0nomogram to predict survival in patients with acute-on-chronic hepatitis B liver failure after liver transplantation","volume":"9","author":"Chen","year":"2021","journal-title":"Ann Transl Med"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.021_bib56","first-page":"4492","article-title":"Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis","volume":"47","author":"Cai","year":"2019","journal-title":"J\u00a0Int Med Res"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib57","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41598-021-81431-0","article-title":"A\u00a0dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators","volume":"11","author":"Yu","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib58","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/liv.14328","article-title":"Risk prediction scores for acute on chronic liver failure development and mortality","volume":"40","author":"Mahmud","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib59","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","article-title":"Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure","volume":"75","author":"Li","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.jhep.2023.04.021_bib60","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","article-title":"Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis","volume":"62","author":"Arroyo","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000002961","article-title":"Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom Critical Care Units","volume":"46","author":"McPhail","year":"2018","journal-title":"Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2023.04.021_bib62","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.jhep.2020.10.024","article-title":"Intensive care management of acute-on-chronic liver failure","volume":"75","author":"Bernal","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhep.2018.04.025","article-title":"The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations","volume":"69","author":"Meersseman","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/17474124.2018.1426459","article-title":"Acute-on-chronic liver failure in chronic hepatitis B: an update","volume":"12","author":"Zhao","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.hbpd.2021.05.010","article-title":"Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: a large, multicenter, retrospective cohort study using a propensity score matching analysis","volume":"20","author":"Xiao","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054773","article-title":"Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib69","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1665-2681(19)30998-6","article-title":"The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis","volume":"12","author":"Yu","year":"2013","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","article-title":"Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure","volume":"25","author":"Sun","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib71","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jvh.13468","article-title":"The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: a prospective cohort study","volume":"28","author":"Zhang","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib72","first-page":"261","article-title":"Short-term entecavir therapy of chronic severe hepatitis B","volume":"8","author":"Chen","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib73","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2010.06.043","article-title":"Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B","volume":"54","author":"Wong","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MCG.0000000000000675","article-title":"Efficacy and safety of lamivudine versus entecavir for treating chronic hepatitis B virus-related acute exacerbation and acute-on-chronic liver failure","volume":"51","author":"Huang","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12879-021-06237-x","article-title":"Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B","volume":"21","author":"Li","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib76","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jhep.2021.06.035","article-title":"Acute-on-chronic liver failure: a complex clinical entity in patients with autoimmune hepatitis","volume":"75","author":"Granito","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib77","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice\u00a0guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib79","article-title":"Approach to the patient with acute severe autoimmune hepatitis","volume":"2","author":"Rahim","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.04.021_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5108781","article-title":"Bacterial infection and predictors of mortality in patients with autoimmune liver disease-associated acute-on-chronic liver failure","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib81","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jceh.2020.08.007","article-title":"Determinants of outcomes in autoimmune hepatitis presenting as acute on chronic liver failure without extrahepatic organ dysfunction upon treatment with steroids","volume":"11","author":"Sharma","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/MEG.0000000000000353","article-title":"Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure","volume":"27","author":"Mendizabal","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.021_bib84","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission, and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.021_bib85","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical\u00a0characteristics of fulminant-type autoimmune hepatitis: an analysis\u00a0of eleven cases","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib86","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib87","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2020.12.033","article-title":"Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: the SURFASA score","volume":"74","author":"de Martin","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib88","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2018.02.022","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis","volume":"69","author":"Serst\u00e9","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib89","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Rahim","year":"2019","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib90","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jhep.2018.06.019","article-title":"Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis","volume":"69","author":"Forrest","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"17","key":"10.1016\/j.jhep.2023.04.021_bib91","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.gastrohep.2012.02.009","article-title":"Portal hypertension: recommendations for evaluation and treatment. Consensus document sponsored by the Spanish association for the study of the liver (AEEH) and the biomedical research network center for liver and digestive diseases (CIBERehd)","volume":"35","author":"Bosch","year":"2012","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib93","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A\u00a0MELD-based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.04.021_bib94","article-title":"Trends and the course of liver cirrhosis and its complications in Germany: nationwide population-based study (2005 to 2018)","volume":"12","author":"Gu","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"25","key":"10.1016\/j.jhep.2023.04.021_bib95","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garc\u00eda-Pag\u00e1n","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib96","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gastrohep.2015.11.012","article-title":"An update on the management of acute\u00a0esophageal variceal bleeding","volume":"40","author":"Cabrera","year":"2017","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib97","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2017.04.042","article-title":"Multicenter external validation of risk stratification criteria for patients with variceal bleeding","volume":"16","author":"Conejo","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib98","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib99","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2020.06.010","article-title":"Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding","volume":"74","author":"Kumar","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D\u2019Amico","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib101","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/liv.12929","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study","volume":"36","author":"Qi","year":"2016","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib103","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib104","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jgh.13593","article-title":"Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding","volume":"32","author":"Njei","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhep.2017.09.002","article-title":"Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results","volume":"68","author":"Thabut","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib106","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.dld.2017.08.002","article-title":"Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice","volume":"49","author":"Bucsics","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.021_bib107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MEG.0000000000000403","article-title":"Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials","volume":"27","author":"Deltenre","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib108","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study","volume":"69","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib109","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3748\/wjg.v20.i7.1790","article-title":"Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.021_bib110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/jgh.12191","article-title":"Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure","volume":"28","author":"Garg","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib111","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2016.10.025","article-title":"Emergency TIPS in a Child-Pugh B patient: when does the\u00a0window of opportunity open and close?","volume":"66","author":"Trebicka","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib112","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/gutjnl-2018-317057","article-title":"Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study","volume":"68","author":"Lv","year":"2019","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2023.04.021_bib113","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.jhep.2020.11.010","article-title":"Management of bacterial and fungal infections in cirrhosis: the MDRO challenge","volume":"75","author":"Fern\u00e1ndez","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib114","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib116","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.021_bib117","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib118","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","article-title":"Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis","volume":"56","author":"Arabi","year":"2012","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.jhep.2023.04.021_bib119","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial","volume":"182","author":"Arabi","year":"2010","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib120","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib121","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0885066618762747","article-title":"Antibiotic use in the intensive care unit: optimization and de-escalation","volume":"33","author":"Campion","year":"2018","journal-title":"J\u00a0Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib122","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","volume":"46","author":"Tabah","year":"2020","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib123","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00134-019-05871-z","article-title":"Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions\u2014a viewpoint of experts","volume":"46","author":"de Waele","year":"2020","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib124","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jhep.2021.12.042","article-title":"Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis","volume":"76","author":"Prado","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.471","article-title":"Prediction of fungal infection development and their impact on survival using the NACSELD cohort","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cmi.2020.04.030","article-title":"Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study","volume":"27","author":"Bartoletti","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"47","key":"10.1016\/j.jhep.2023.04.021_bib127","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.3748\/wjg.v26.i47.7485","article-title":"Invasive fungal infection before and after liver transplantation","volume":"26","author":"Ferrarese","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib128","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2017.06.013","article-title":"Sepsis\u00a0in alcohol-related liver disease","volume":"67","author":"Gustot","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2023.04.021_bib129","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","article-title":"Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib130","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/myc.13170","article-title":"Quantification of 1,3-\u03b2-d-glucan by Wako \u03b2-glucan assay for rapid exclusion of invasive fungal infections in critical patients: a diagnostic test accuracy study","volume":"63","author":"Cento","year":"2020","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCC.0000000000000584","article-title":"Artificial liver support in acute and acute-on-chronic liver failure","volume":"25","author":"Larsen","year":"2019","journal-title":"Curr Opin Crit Care"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib132","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0038-1675334","article-title":"Emerging role of extracorporeal support in acute and acute-on-chronic liver failure: recent developments","volume":"39","author":"MacDonald","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jhep.2023.04.021_bib133","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/HMER.S180246","article-title":"Comparison of extracorporeal cellular therapy (ELAD\u00ae) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure","volume":"10","author":"Duan","year":"2018","journal-title":"Hepat Med"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib134","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13613-020-00795-0","article-title":"Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis","volume":"11","author":"Ocskay","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jhep.2023.04.021_bib136","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819879565","article-title":"Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity","volume":"12","author":"Ba\u00f1ares","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib137","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3748\/wjg.v26.i2.219","article-title":"Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review","volume":"26","author":"Tan","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib138","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/scrt22","article-title":"Human CD34+ cells mobilized by granulocyte colony-stimulating factor ameliorate radiation-induced liver damage in mice","volume":"1","author":"Li","year":"2010","journal-title":"Stem Cel Res Ther"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib139","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/SLA.0b013e31823d7d08","article-title":"Infusion of CD133\u00a0+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study","volume":"255","author":"Esch","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2023.04.021_bib140","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.ejim.2016.09.006","article-title":"Effects of granulocyte-colony stimulating factor (G-CSF) on stem cell mobilization in patients with liver failure","volume":"36","author":"Engelmann","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.jhep.2023.04.021_bib141","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791","article-title":"Granulocyte colony-stimulating factor and its receptor","volume":"78","author":"Demetri","year":"1991","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib142","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib143","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3748\/wjg.v19.i7.1104","article-title":"Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acuteon-chronic liver failure","volume":"19","author":"Duan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib144","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)","volume":"75","author":"Engelmann","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.021_bib145","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep4.1722","article-title":"Frailty and sarcopenia in acute-on-chronic liver failure","volume":"5","author":"Puchades Renau","year":"2021","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib146","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib147","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"European Association for the Study of the Liver A. EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2023.04.021_bib148","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib149","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/apt.12252","article-title":"Meta-Analysis: oral or enteral nutritional supplementation in cirrhosis","volume":"37","author":"Ney","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib150","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/lt.25602","article-title":"Nutritional assessment in inpatients with cirrhosis can Be improved after training and is associated with lower readmissions","volume":"25","author":"Reuter","year":"2019","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.jhep.2023.04.021_bib151","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/lt.26100","article-title":"Inpatient frailty assessment is feasible and predicts nonhome discharge and mortality in decompensated cirrhosis","volume":"27","author":"Serper","year":"2021","journal-title":"Liver Transplant"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib152","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000211","article-title":"Validation of the clinical frailty scale for the prediction of mortality in patients with liver cirrhosis","volume":"11","author":"Kremer","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib153","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-015-4015-z","article-title":"The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis","volume":"61","author":"Borhofen","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12072134","article-title":"NUTRIC and modified NUTRIC are accurate predictors of outcome in end-stage liver disease: a validation in critically ill patients with liver cirrhosis","volume":"12","author":"Mayr","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.021_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092152","article-title":"Nutrition risk assessment using the modified NUTRIC score in cirrhotic patients with acute gastroesophageal variceal bleeding: prevalence of high nutrition risk and its independent prognostic value","volume":"11","author":"Tsai","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib156","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/CCM.0000000000001525","article-title":"Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.)","volume":"44","author":"Taylor","year":"2016","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib157","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clnu.2009.05.016","article-title":"ESPEN Guidelines on Parenteral Nutrition: adult renal failure","volume":"28","author":"Cano","year":"2009","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib158","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.clnu.2020.07.034","article-title":"Mortality associated with new risk classification of developing refeeding syndrome in critically ill patients: a cohort study","volume":"40","author":"Yoshida","year":"2021","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib159","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1155\/2012\/945707","article-title":"A\u00a0meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis","volume":"26","author":"Antar","year":"2012","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib160","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.gie.2010.06.043","article-title":"Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series","volume":"72","author":"Baltz","year":"2010","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib161","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib162","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib163","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/jgh.15400","article-title":"Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: an open-label randomized controlled trial","volume":"36","author":"Kulkarni","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8226","key":"10.1016\/j.jhep.2023.04.021_bib164","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0140-6736(81)91617-2","article-title":"Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients","volume":"317","author":"Lebrec","year":"1981","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib165","article-title":"Beta-blockers in cirrhosis: evidence-based indications and limitations","volume":"2","author":"Rodrigues","year":"2020","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib166","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serst\u00e9","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib167","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib168","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.021_bib169","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gutjnl-2020-322712","article-title":"Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes","volume":"70","author":"Jachs","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib170","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.15439","article-title":"Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis","volume":"50","author":"Tergast","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhep.2023.04.021_bib171","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib172","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2018.07.007","article-title":"Liver transplantation in patients with multiple organ failures: feasibility and outcomes","volume":"69","author":"Thuluvath","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib173","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2018.12.007","article-title":"Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation","volume":"156","author":"Sundaram","year":"2019","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jhep.2023.04.021_bib174","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/ajt.15852","article-title":"Liver transplantation for critically ill cirrhotic patients: stratifying utility based on pretransplant factors","volume":"20","author":"Artzner","year":"2020","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib175","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2021.03.030","article-title":"Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA\/EF-CLIF collaborative study (ECLIS)","volume":"75","author":"Belli","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib176","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/apt.15988","article-title":"Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy","volume":"52","author":"Sundaram","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib177","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30624","article-title":"Patients with acute on chronic liver failure grade 3 have greater 14-day waitlist mortality than status-1a patients","volume":"70","author":"Sundaram","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib178","article-title":"Early transplantation maximizes survival in severe acute-on-chronic liver failure: results of a Markov decision process model","volume":"3","author":"Zhang","year":"2021","journal-title":"JHEP Rep"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.021_bib179","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.transproceed.2011.08.110","article-title":"Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience","volume":"43","author":"Umgelter","year":"2011","journal-title":"Transpl Proc"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/liv.13355","article-title":"Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation","volume":"37","author":"Levesque","year":"2017","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib181","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/lt.26408","article-title":"Risk factors for posttransplantation mortality in recipients with grade 3 acute-on-chronic liver failure: analysis of a North American consortium","volume":"28","author":"Sundaram","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2023.04.021_bib182","article-title":"When is a critically ill cirrhotic patient too sick to transplant? Development of consensus criteria by a multidisciplinary panel of 35 international experts","volume":"561\u20138","author":"Weiss","year":"2021","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib183","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/SLA.0b013e3182365081","article-title":"Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era","volume":"254","author":"Dutkowski","year":"2011","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib184","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/lt.25362","article-title":"Pilot, open, randomized, prospective trial for normothermic machine perfusion evaluation in liver transplantation from older donors","volume":"25","author":"Ghinolfi","year":"2019","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib185","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/SLA.0000000000005110","volume":"274","author":"Czigany","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2023.04.021_bib186","unstructured":"http:\/\/www.eltr.org. European Liver Transplant Registry"},{"issue":"10","key":"10.1016\/j.jhep.2023.04.021_bib187","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/lt.20875","article-title":"Documented deaths of hepatic lobe donors for living donor liver transplantation","volume":"12","author":"Trotter","year":"2006","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.jhep.2023.04.021_bib188","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/lt.23575","article-title":"Incidence of death\u00a0and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey","volume":"19","author":"Cheah","year":"2013","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.jhep.2023.04.021_bib189","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/lt.21030","article-title":"Three-quarters of right liver donors experienced postoperative complications","volume":"13","author":"Yi","year":"2007","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.jhep.2023.04.021_bib190","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jss.2013.03.008","article-title":"Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases","volume":"183","author":"Duan","year":"2013","journal-title":"J\u00a0Surg Res"},{"issue":"8","key":"10.1016\/j.jhep.2023.04.021_bib191","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14739","article-title":"Outcomes of living-donor liver transplantation for acute-on-chronic liver failure based on newly proposed criteria in Japan","volume":"36","author":"Toshima","year":"2022","journal-title":"Clin Transpl"},{"issue":"3","key":"10.1016\/j.jhep.2023.04.021_bib192","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/lt.25395","article-title":"Living donor liver transplantation for acute-on-chronic liver failure","volume":"25","author":"Yadav","year":"2019","journal-title":"Liver Transplant"},{"issue":"7","key":"10.1016\/j.jhep.2023.04.021_bib193","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/ajt.14198","article-title":"Adult living donor liver transplantation for acute-on-chronic liver failure in high\u2013model for end-stage liver disease score patients","volume":"17","author":"Moon","year":"2017","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2023.04.021_bib194","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2021.01.018","article-title":"New clinical and pathophysiological perspectives defining the trajectory of cirrhosis","volume":"75","author":"Jalan","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.04.021_bib195","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2024.03.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823002441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823002441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T12:25:09Z","timestamp":1702643109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":195,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0168827823002441"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.04.021","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}